Related Experiment Video
Updated: Jul 10, 2026

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3
Jos L J van der Velden1, Annemie M W J Schols1, Jodil Willems1
1Department of Respiratory Medicine, Nutrition and Toxicology Research Institute Maastricht, Maastricht University, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
Abstract:
Skeletal muscle atrophy is a prominent and disabling feature in many chronic diseases. Prevention or reversal of muscle atrophy by stimulation of skeletal muscle growth could be an important therapeutic strategy. Glycogen synthase kinase 3beta (GSK-3beta) has been implicated in the negative regulation of skeletal muscle growth. Since myogenic differentiation is an essential part of muscle growth, we investigated if inhibition of GSK-3beta is sufficient to stimulate myogenic differentiation and whether this depended on regulation of the transcription factor nuclear factor of activated T-cells (NFAT). In both myogenically converted mouse embryonic fibroblasts and C2C12 myoblasts, deficiency of GSK-3beta protein (activity) resulted in enhanced myotube formation and muscle-specific gene expression during differentiation, which was reversed by reintroduction of wild type but not kinase-inactive (K85R) GSK-3beta. In addition, GSK-3beta inhibition restored myogenic differentiation following calcineurin blockade, which suggested the involvement of NFAT. GSK-3beta-deficient mouse embryonic fibroblasts or myoblasts displayed enhanced nuclear translocation of NFATc3 and elevated NFAT-sensitive promoter transactivation, which was reduced by reintroducing wild type, but not K85R GSK-3beta. Overexpression of NFATc3 increased muscle gene promoter transactivation, which was abolished by co-expression of wild type GSK-3beta. Finally, stimulation of muscle gene expression observed following GSK-3beta inhibition was strongly attenuated in NFATc3-deficient myoblasts, indicating that this response requires NFATc3. Collectively, our data demonstrate negative regulation of myogenic differentiation by GSK-3beta through a transcriptional mechanism that depends on NFATc3. Inhibition of GSK-3beta may be a potential strategy in prevention or treatment of muscle atrophy.
Insights
Inhibiting GSK-3beta promotes muscle growth by enhancing myogenic differentiation via NFATc3. This finding offers a potential strategy for treating skeletal muscle atrophy.
Area of Science:
- Cell Biology
- Molecular Biology
- Physiology
Background:
- Skeletal muscle atrophy is a debilitating condition linked to chronic diseases.
- Stimulating muscle growth presents a therapeutic avenue for combating atrophy.
- Glycogen synthase kinase 3beta (GSK-3beta) negatively regulates skeletal muscle growth.
Purpose of the Study:
- To investigate if inhibiting GSK-3beta stimulates myogenic differentiation.
- To determine if GSK-3beta's effect on differentiation is mediated by the transcription factor NFAT.
- To explore GSK-3beta inhibition as a therapeutic strategy for muscle atrophy.
Main Methods:
- Utilized mouse embryonic fibroblasts and C2C12 myoblasts.
- Assessed myotube formation and muscle-specific gene expression.
- Investigated nuclear translocation and promoter transactivation of NFATc3.
- Employed GSK-3beta deficiency, reintroduction of wild-type and mutant GSK-3beta, calcineurin blockade, and NFATc3 deficiency models.
Main Results:
- GSK-3beta deficiency enhanced myotube formation and muscle gene expression.
- Inhibition of GSK-3beta restored differentiation after calcineurin blockade, indicating NFAT involvement.
- GSK-3beta deficiency led to increased NFATc3 nuclear translocation and activity.
- NFATc3 deficiency attenuated the muscle gene expression stimulated by GSK-3beta inhibition.
Conclusions:
- GSK-3beta negatively regulates myogenic differentiation through an NFATc3-dependent transcriptional mechanism.
- Inhibiting GSK-3beta shows promise for preventing or treating skeletal muscle atrophy.
Related Concept Videos
Master Transcription Regulators
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
The JAK-STAT Signaling Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
